STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1025 participants.
Also called NCT07278310
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,025 participants
- Sponsor
- MiRus
- Registry
-
NCT07278310
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07278310. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
- Condition
- Symptomatic Severe Native Aortic Stenosis
- Condition
- Aortic Stenosis
- Intervention (Device)
- TAVR Device
- Intervention (Device)
- Siegel TAVR Device
- Lead sponsor
- MiRus
Record details
- Record id
cardio:ct-nct07278310- Content hash
008a73fa459db3275bfab0bccc049178a5f44e9e213b164f68071bfb431a4da7